2023
DOI: 10.1007/s42770-023-00939-x
|View full text |Cite
|
Sign up to set email alerts
|

A new extracellular glutaminase and urease-free l-asparaginase from Meyerozyma guilliermondii

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 38 publications
0
4
0
Order By: Relevance
“…The existence of l -asparaginase was further confirmed by using l -asparaginase-specific antibody, and the enzymatic product from tomato has two subunits with molecular weights of 50 and 30 kDa respectively. The optimum conditions for l -asparaginase activity from tomato are shown to vary with other sources. …”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The existence of l -asparaginase was further confirmed by using l -asparaginase-specific antibody, and the enzymatic product from tomato has two subunits with molecular weights of 50 and 30 kDa respectively. The optimum conditions for l -asparaginase activity from tomato are shown to vary with other sources. …”
Section: Resultsmentioning
confidence: 99%
“…The optimum conditions for l -asparaginase activity from tomato are shown to vary with other sources. 48 50 …”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Many commercial enzymes now use a combination of protein engineering and rational design methods based on computer modeling of proteins, which complements protein engineering and makes it more precise and efficient [16]. L-ASNases for therapeutic use are currently produced exclusively from Escherichia coli and Erwinia chrysanthemi [17], which are FDA-approved drugs [8]. Currently, the World Health Organization (WHO) has included L-ASNase in the list of essential medicines [18].…”
Section: Of 60mentioning
confidence: 99%